New Study Paxlovid Provides ZERO Benefit For 40-65 Year Olds

First published at 13:06 UTC on November 10th, 2022.
subscribers

A recent Israeli study conducted with more than 100,000 subjects found that Pfizer’s COVID treatment drug, Paxlovid, showed no measurable benefit to patients between 40-65 years of age. These findings are remarkable considering that Paxlovid has bee…

MORE
CategoryNone
SensitivityNormal - Content that is suitable for ages 16 and over
DISCUSS THIS VIDEO